FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johanna Groener

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Henrik Gold; Johanna E M Groener; Maria Joao Ferraz; Gabor E Linthorst; Johan Lugtenburg; Mina Mirzaian; Herman S Overkleeft; Johannes M Aerts; Jeroen D C Codée; Nick Dekker; Gijs A van der Marel; Ben J H M Poorthuis
Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry.
Laura van Dussen; Mario Maas; Elizabeth Morris; Johannes M F G Aerts; Erik M Akkerman; Timothy M Cox; Patrick B Deegan; Johanna E M Groener; Erik J Hendriks; Carla E M Hollak
Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes.
Carla E M Hollak; Dirk J Lefeber; Gabor E Linthorst; M Mannens; Wouter Meersseman; Eva Morava; M F Mulder; Klary E Niezen-Koning; J M F G Aerts; Erik M Akkerman; David Cassiman; E S V de Sonnaville; Johanna E M Groener; Gepke Visser; Ron A Wevers; Frits A Wijburg; B J H M Poorthuis
Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johanna Groener (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Henrik Gold; Johanna E M Groener; Maria Joao Ferraz; Gabor E Linthorst; Johan Lugtenburg; Mina Mirzaian; Herman S Overkleeft; Johannes M Aerts; Jeroen D C Codée; Nick Dekker; Gijs A van der Marel; Ben J H M Poorthuis
Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry.
Clinical chemistry 2013;59(3):547-56.
2012: Laura van Dussen; Mario Maas; Elizabeth Morris; Johannes M F G Aerts; Erik M Akkerman; Timothy M Cox; Patrick B Deegan; Johanna E M Groener; Erik J Hendriks; Carla E M Hollak
Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes.
Haematologica 2012;97(12):1850-4.
2012: Carla E M Hollak; Dirk J Lefeber; Gabor E Linthorst; M Mannens; Wouter Meersseman; Eva Morava; M F Mulder; Klary E Niezen-Koning; J M F G Aerts; Erik M Akkerman; David Cassiman; E S V de Sonnaville; Johanna E M Groener; Gepke Visser; Ron A Wevers; Frits A Wijburg; B J H M Poorthuis
Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.
Molecular genetics and metabolism 2012;107(3):526-33.
2012: Saskia M Rombach; Bas van den Bogaard; Bert-Jan H van den Born; Eric de Groot; Johanna E M Groener; Carla E M Hollak; Gabor E Linthorst; B J H M Poorthuis; Johannes M F G Aerts
Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine.
Hypertension 2012;60(4):998-1005.
2012: Saskia M Rombach; Frits A Wijburg; Mina Mirzaian; B J H M Poorthuis; Johannes M F G Aerts; Wilma Donker-Koopman; Johanna E M Groener; Erik Hendriks; Carla E M Hollak; Sijmen Kuiper; Gabor E Linthorst
Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome.
PloS one 2012;7(10):e47805.
2011: Anna Tylki-Szymańska; Johanna E M Groener; Elżbieta Jurkiewicz; Marek Leszek Kamiński; Agnieszka Lugowska; Barbara Czartoryska
Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form--no positive effects after 2-years of miglustat therapy.
Molecular genetics and metabolism 2011;104(4):627-30.
2011: Nick Dekker; Maria J Ferraz; Karen Ghauharali; Johanna E M Groener; Carla E M Hollak; Mario Maas; Pramod K Mistry; Herman S Overkleeft; Saskia Scheij; Dave Speijer; Anna Tylki-Szymanska; Mariëlle J Van Breemen; Laura van Dussen; Frits A Wijburg; Rolf G Boot; Johannes M Aerts
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
Blood 2011;118(16):e118-27.
2011: Johannes M F G Aerts; Josanne Cox-Brinkman; Nick Dekker; Henrik Gold; Johanna E M Groener; Carla E M Hollak; Maria Joao Ferraz; Wouter W Kallemeijn; Gertjan Kramer; Gabor E Linthorst; Herman S Overkleeft; B J H M Poorthuis; Saskia M Rombach; Mariëlle J Van Breemen; Gijs A van der Marel; Wouter Wegdam; Martin D Witte; Rolf G Boot
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.
Journal of inherited metabolic disease 2011;34(3):605-19.
2011: Johanna E M Groener; Mireille J Serlie; Aldi Poppema; Mina Mirzaian; Johannes M Aerts
Ceramide in lipid emulsions used in parenteral nutrition: an innocent bystander?
JPEN. Journal of parenteral and enteral nutrition 2011;35(2):270-1.
2011: Bouwien E Smid; Johannes M F G Aerts; Johanna E M Groener; Carla E M Hollak; Sijmen Kuiper; Mina Mirzaian; Hermen S Overkleeft; B J H M Poorthuis; Saskia M Rombach; Gabor E Linthorst
Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients.
Orphanet journal of rare diseases 2011;6():69.
2011: Johannes M Aerts; Jan Aten; Florence M Bietrix; Nora Bijl; Rolf G Boot; Nick Dekker; Albert K Groen; Johanna E M Groener; Mirjam Langeveld; Elisa Lombardo; Roelof Ottenhoff; Mireille Serlie; Marco van Eijk; Cindy van Roomen; Tom Wennekes; Herman S Overkleeft
Glycosphingolipids and insulin resistance.
Advances in experimental medicine and biology 2011;721():99-119.
2010: S M Rombach; N Dekker; M G Bouwman; Gabor E Linthorst; A H Zwinderman; Frits A Wijburg; S Kuiper; M A Vd Bergh Weerman; Johanna E M Groener; B J Poorthuis; Carla E M Hollak; J M F G Aerts
Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease.
Biochimica et biophysica acta 2010;1802(9):741-8.
2010: Jooske M F Boomsma; Laura van Dussen; Maaike G Wiersma; Johanna E M Groener; Johannes M F G Aerts; Mario Maas; Carla E M Hollak
Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.
Blood cells, molecules & diseases 2010;44(3):181-7.
2010: Rinke Stienstra; Fredy Saudale; Caroline Duval; Shohreh Keshtkar; Johanna E M Groener; Nico van Rooijen; Bart Staels; Sander Kersten; Michael Müller
Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.
Hepatology (Baltimore, Md.) 2010;51(2):511-22.
2010: Tom Wennekes; Alfred J Meijer; Albert K Groen; Rolf G Boot; Johanna E M Groener; Martin van Eijk; Roelof Ottenhoff; Nora Bijl; Karen Ghauharali; Hang Song; Tom J O'Shea; Hanlan Liu; Nelson Yew; Diane Copeland; Richard J B H N van den Berg; Gijsbert A van der Marel; Herman S Overkleeft; Johannes M Aerts
Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation.
Journal of medicinal chemistry 2010;53(2):689-98.
2009: Ruud A Bank; Johanna E M Groener; Justus J van Gemund; Petra D Maaswinkel; Kees A Hoeben; Herman A Schut; Vincent Everts
Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients.
Molecular genetics and metabolism 2009;97(3):196-201.
2009: Karen Ghauharali-van der Vlugt; Anton P Bussink; Johanna E M Groener; Rolf G Boot; Johannes M F G Aerts
Detection of chitinase activity by 2-aminobenzoic acid labeling of chito-oligosaccharides.
Analytical biochemistry 2009;384(1):191-3.
2008: Anouk C Vedder; Frank Breunig; Wilma E Donker-Koopman; Kevin Mills; Elisabeth Young; Bryan Winchester; Ineke J M ten Berge; Johanna E M Groener; johannes aerts; Christoph Wanner; Carla E M Hollak
Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3.
Molecular genetics and metabolism 2008;94(3):319-25.
2008: Maarten R Soeters; Hans P Sauerwein; Peter F Dubbelhuis; Johanna E M Groener; Mariëtte T Ackermans; Eric Fliers; Johannes M Aerts; Mireille J Serlie
Muscle adaptation to short-term fasting in healthy lean humans.
The Journal of clinical endocrinology and metabolism 2008;93(7):2900-3.
2008: johannes aerts; Mariëlle J Van Breemen; Anton P Bussink; Karen Ghauharali; Richard Sprenger; Rolf G Boot; Johanna E M Groener; Carla E M Hollak; Mario Maas; Suzanne Smit; Huub C Hoefsloot; Age K Smilde; Johannes Pc Vissers; Sheryas de Jong; Dave Speijer; Chris G de Koster
Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2008;97(457):7-14.
2008: Karen Ghauharali-van der Vlugt; Mirjam Langeveld; Aldi Poppema; Sijmen Kuiper; Carla E M Hollak; johannes aerts; Johanna E M Groener
Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease.
Clinica chimica acta; international journal of clinical chemistry 2008;389(1-2):109-13.
2008: Mirjam Langeveld; Karen J M Ghauharali; Hans P Sauerwein; Mariëtte T Ackermans; Johanna E M Groener; Carla E M Hollak; johannes aerts; Mireille J Serlie
Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance.
The Journal of clinical endocrinology and metabolism 2008;93(3):845-51.
2008: johannes aerts; Johanna E M Groener; Sijmen Kuiper; Wilma E Donker-Koopman; Anneke Strijland; Roelof Ottenhoff; Cindy van Roomen; Mina Mirzaian; Frits A Wijburg; Gabor E Linthorst; Anouk C Vedder; Saskia M Rombach; J Cox-Brinkman; Pentti Somerharju; Rolf G Boot; Carla E M Hollak; Roscoe O Brady; B J H M Poorthuis
Elevated globotriaosylsphingosine is a hallmark of Fabry disease.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(8):2812-7.
2008: Johanna E M Groener; B J H M Poorthuis; Sijmen Kuiper; Carla E M Hollak; johannes aerts
Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention.
Biochimica et biophysica acta 2008;1781(1-2):72-8.
2007: Maarten R Soeters; Hans P Sauerwein; Johanna E M Groener; johannes aerts; Mariëtte T Ackermans; Jan F C Glatz; Eric Fliers; Mireille J Serlie
Gender-related differences in the metabolic response to fasting.
The Journal of clinical endocrinology and metabolism 2007;92(9):3646-52.
2007: Aricha Schoonhoven; Bernard Rudensky; Debbie Elstein; Ari Zimran; Carla E M Hollak; Johanna E M Groener; johannes aerts
Monitoring of Gaucher patients with a novel chitotriosidase assay.
Clinica chimica acta; international journal of clinical chemistry 2007;381(2):136-9.
2007: Costel Spanu; R H Lekanne dit Deprez; Johanna E M Groener; C C Nita
Gene symbol: GLA.
Human genetics 2007;121(2):295.
2007: Johanna E M Groener; B J H M Poorthuis; Sijmen Kuiper; Mariette T J Helmond; Carla E M Hollak; johannes aerts
HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma.
Clinical chemistry 2007;53(4):742-7.
2007: Mireille J Serlie; Alfred J Meijer; Johanna E M Groener; M Duran; Erik Endert; Eric Fliers; johannes aerts; Hans P Sauerwein
Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.
The Journal of clinical endocrinology and metabolism 2007;92(4):1524-9.
2007: Maaike de Fost; johannes aerts; Johanna E M Groener; Mario Maas; Erik M Akkerman; Maaike G Wiersma; Carla E M Hollak
Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial.
Haematologica 2007;92(2):215-21.
2007: Anouk C Vedder; Gabor E Linthorst; Mariëlle J Van Breemen; Johanna E M Groener; F J Bemelman; Anneke Strijland; marcel mannens; johannes aerts; Carla E M Hollak
The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels.
Journal of inherited metabolic disease 2007;30(1):68-78.
2007: Anouk C Vedder; Gabor E Linthorst; Gunnar Houge; Johanna E M Groener; Els E Ormel; Berto J Bouma; johannes aerts; Asle Hirth; Carla E M Hollak
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg.
PloS one 2007;2(7):e598.
2007: Mireille J Serlie; Gideon Allick; Johanna E M Groener; Mariëtte T Ackermans; Rik Heijligenberg; Barbara C Voermans; johannes aerts; Alfred J Meijer; Hans P Sauerwein
Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.
The Journal of clinical endocrinology and metabolism 2007;92(1):166-71.
2006: Anouk C Vedder; J Cox-Brinkman; Carla E M Hollak; Gabor E Linthorst; Johanna E M Groener; Mariette T J Helmond; Saskia Scheij; johannes aerts
Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy.
Molecular genetics and metabolism 2006;89(3):239-44.
2006: Rolf G Boot; Marri Verhoek; Mirjam Langeveld; G Herma Renkema; Carla E M Hollak; Jan J Weening; Wilma E Donker-Koopman; Johanna E M Groener; johannes aerts
CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.
Journal of inherited metabolic disease 2006;29(4):564-71.
2006: Maaike de Fost; Carla E M Hollak; Johanna E M Groener; johannes aerts; Mario Maas; Ludger W Poll; Maaike G Wiersma; Dieter Häussinger; Sarah Brett; Nicole Brill; Stephan vom Dahl
Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.
Blood 2006;108(3):830-5.
2006: johannes aerts; Carla E M Hollak; Rolf G Boot; Johanna E M Groener; Mario Maas
Substrate reduction therapy of glycosphingolipid storage disorders.
Journal of inherited metabolic disease 2006;29(2-3):449-56.
2005: johannes aerts; Carla E M Hollak; Mariëlle J Van Breemen; Mario Maas; Johanna E M Groener; Rolf G Boot
Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2005;94(447):43-6; discussion 37-8.
2005: J Brinkman; Frits A Wijburg; Carla E M Hollak; Johanna E M Groener; Marri Verhoek; Saskia Scheij; J Aten; Rolf G Boot; johannes aerts
Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease.
Journal of inherited metabolic disease 2005;28(1):13-20.
2004: Elles G Berger-Plantinga; Jan A L Vanneste; Johanna E M Groener; Mary J van Schooneveld
Adult-onset dementia and retinitis pigmentosa due to mucopolysaccharidosis III-C in two sisters.
Journal of neurology 2004;251(4):479-81.
2004: Annick Raas-Rothschild; Ruth Bargal; O Goldman; Edna Ben-Asher; Johanna E M Groener; A Toutain; E Stemmer; Ziva Ben-Neriah; H Flusser; F A Beemer; M Penttinen; Tsviya Olender; Azaria J J T Rein; Gideon Bach; Marsha Zeigler
Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III.
Journal of medical genetics 2004;41(4):e52.
2003: Begoña Aguilera; Karen Ghauharali-van der Vlugt; Mariette T J Helmond; Jos M M Out; Wilma E Donker-Koopman; Johanna E M Groener; Rolf G Boot; G Herma Renkema; Gijsbert A van der Marel; Jacques H van Boom; Herman S Overkleeft; johannes aerts
Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase.
The Journal of biological chemistry 2003;278(42):40911-6.
2003: Johanna E M Groener; PD Maaswinkel-Mooy; Vincent T H B M Smit; M van der Hoeven; Jaap Bakker; Y Campos; A d'Azzo
New mutations in two Dutch patients with early infantile galactosialidosis.
Molecular genetics and metabolism 2003;78(3):222-8.
2003: W C G Overweg-Plandsoen; Johanna E M Groener; D Wang; Willem Onkenhout; Oebele F Brouwer; Henk D Bakker; D C De Vivo
GLUT-1 deficiency without epilepsy--an exceptional case.
Journal of inherited metabolic disease 2003;26(6):559-63.
2002: Willem Onkenhout; Johanna E M Groener; NM Verhoeven; C Yin; L A E M Laan
L-Arabinosuria: a new defect in human pentose metabolism.
Molecular genetics and metabolism 2002;77(1-2):80-5.
2002: Femke de Loos; Karin M L C Huijben; Nicole C A J van der Kar; Leo A H Monnens; Lambert P van den Heuvel; Johanna E M Groener; Ronald A de Moor; Ron A Wevers
Hemolytic uremic syndrome attributable to Streptococcus pneumoniae infection: a novel cause for secondary protein N-glycan abnormalities.
Clinical chemistry 2002;48(5):781-4.
2002: Anna Tylki-Szymańska; Barbara Czartoryska; Johanna E M Groener; Agnieszka Ługowska
Clinical variability in mucolipidosis III (pseudo-Hurler polydystrophy).
American journal of medical genetics 2002;108(3):214-8.
2001: SM Jansen; Johanna E M Groener; Wilhelmina Bax; B J H M Poorthuis
Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis.
Journal of inherited metabolic disease 2001;24(5):577-86.
2001: SM Jansen; Johanna E M Groener; Wilhelmina Bax; A Suter; P Saftig; P Somerharju; B J H M Poorthuis
Biosynthesis of phosphatidylcholine from a phosphocholine precursor pool derived from the late endosomal/lysosomal degradation of sphingomyelin.
The Journal of biological chemistry 2001;276(22):18722-7.
2001: Henk D Bakker; M L de Sonnaville; P Vreken; N G G M Abeling; Johanna E M Groener; J L M Keulemans; Otto P van Diggelen
Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: no association with neuroaxonal dystrophy?
European journal of human genetics : EJHG 2001;9(2):91-6.
2000: Johanna E M Groener; Wilhelmina Bax; Cristiana Stuani; Franco Pagani
Difference in substrate specificity between human and mouse lysosomal acid lipase: low affinity for cholesteryl ester in mouse lysosomal acid lipase.
Biochimica et biophysica acta 2000;1487(2-3):155-62.
2000: Miek C Jong; WL Hendriks; LC van Vark; Vivian E H Dahlmans; Johanna E M Groener; Louis M Havekes
Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(1):144-51.
1999: Johanna E M Groener; F L de Graaf; B J H M Poorthuis; Humphrey H H Kanhai
Prenatal diagnosis of lysosomal storage diseases using fetal blood.
Prenatal diagnosis 1999;19(10):930-3.
1999: B J H M Poorthuis; Ron A Wevers; Wim J Kleijer; Johanna E M Groener; Jan G N de Jong; Sonja van Weely; Klary E Niezen-Koning; Otto P van Diggelen
The frequency of lysosomal storage diseases in The Netherlands.
Human genetics 1999;105(1-2):151-6.
1999: M Claeys; Mark A van der Hoeven; C E M de Die-Smulders; Jaap Bakker; J P Offermans; P Ph Forget; Johanna E M Groener; L J M Spaapen
Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites.
Journal of inherited metabolic disease 1999;22(5):666-7.
1999: SM Jansen; Johanna E M Groener; B J H M Poorthuis
Lysosomal phospholipase activity is decreased in mucolipidosis II and III fibroblasts.
Biochimica et biophysica acta 1999;1436(3):363-9.
1996: Johanna E M Groener; W Bax; B J H M Poorthuis
Metabolic fate of oleic acid derived from lysosomal degradation of cholesteryl oleate in human fibroblasts.
Journal of lipid research 1996;37(11):2271-9.
1995: Wim J Kleijer; M van der Kraan; Marian A Kroos; Johanna E M Groener; Otto P van Diggelen; Arnold J J Reuser; Ans T Van Der Ploeg
Prenatal diagnosis of glycogen storage disease type II: enzyme assay or mutation analysis?
Pediatric research 1995;38(1):103-6.
1995: Arie Van Tol; Johanna E M Groener; Leo Scheek; Teus van Gent; J Veenstra; H Van de Pol; Henk F.J. Hendriks; Gertjan Schaafsma
Induction of net mass lipid transfer reactions in plasma by wine consumption with dinner.
European journal of clinical investigation 1995;25(6):390-5.
1995: Y Guo; W He; A M Boer; Ron A Wevers; A M de Bruijn; Johanna E M Groener; Carla E M Hollak; johannes aerts; H Galjaard; Otto P van Diggelen
Elevated plasma chitotriosidase activity in various lysosomal storage disorders.
Journal of inherited metabolic disease 1995;18(6):717-22.
1991: H Speijer; Johanna E M Groener; E van Ramshorst; Arie Van Tol
Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma.
Atherosclerosis 1991;90(2-3):159-68.
1991: Johanna E M Groener; E M van Ramshorst; M B Katan; R P Mensink; Arie Van Tol
Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects.
Atherosclerosis 1991;87(2-3):221-6.
1991: Arie Van Tol; Leo Scheek; Johanna E M Groener
Net mass transfer of cholesteryl esters from low density lipoproteins to high density lipoproteins in plasma from normolipidemic subjects.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(1):55-63.
1991: Arie Van Tol; Teus van Gent; Leo Scheek; Johanna E M Groener; L M Sassen; Jos M J Lamers; Pieter D Verdouw
Lipoprotein structure and metabolism during progression and regression of atherosclerosis in pigs fed with fish oil-derived fatty acids.
Advances in experimental medicine and biology 1991;285():417-21.
1990: Johanna E M Groener; E van Ramshorst; M Katan; R Mensink; Arie Van Tol
Diet modulates plasma neutral lipid transfer protein activity in normolipidemic human subjects.
Klinische Wochenschrift 1990;68 Suppl 22():106-7.
1989: Johanna E M Groener; Teus van Gent; Arie Van Tol
Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
Biochimica et biophysica acta 1989;1002(1):93-100.
1988: Arie Van Tol; Leo Scheek; Johanna E M Groener
Cholesterol esterification and net mass transfer of cholesterylesters and triglycerides in plasma from healthy subjects and hyperlipidemic coronary heart disease patients.
Advances in experimental medicine and biology 1988;243():231-7.